HIV and AIDS Trial, Recruiting NCT06656676 Sponsor: University of Colorado, Denver Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06656676
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For transgender women:

  • People who identify as a transgender woman (assigned male at birth, with a feminine gender identity)
  • People between the ages of 18 and 65
  • People who currently live in the Denver area
  • People who speak English or Spanish
  • People who have tested HIV-negative
  • People who did not take part in the earlier development of the WePrEP program
  • People who are not currently taking PrEP, but who express an interest in doing more to protect themselves from HIV

For PrEP service providers:

  • People who live in the Denver area and, as part of their job, discuss PrEP with potential users
  • People who have helped at least one transgender woman make a decision about PrEP within the last month
  • People who did not take part in the earlier development of the WePrEP program

Who may not be able to join:

For transgender women:

  • People who are currently living with HIV
  • People who do not meet one or more of the inclusion criteria listed above

For PrEP service providers:

  • People who do not live in the Denver area
  • People who do not meet one or more of the inclusion criteria listed above

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 303-734-8541

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
29 January 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Feasibility; Acceptability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov